(MENAFNEditorial)
Global Markets Direct's 'ArmaGen Technologies Inc. - Product Pipeline Review - 2014' provides an overview of the ArmaGen Technologies Inc.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of ArmaGen Technologies Inc.'s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action (MoA) route of administration (RoA) and molecule type. It also reviews latest updates and featured news and press releases along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases Company/University websites SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally processes including live news & deals tracking browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Full Report Details at
- http://www.fastmr.com/prod/900898_armagen_technologies_inc_product_pipeline_review.aspx?afid=101
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
* The report provides brief overview of ArmaGen Technologies Inc. including business description key information and facts and its locations and subsidiaries
* The report reviews current pipeline of ArmaGen Technologies Inc.'s human therapeutic division and enlists all their major and minor projects
* The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
* Special feature on out-licensed and partnered product portfolio
* The report summarizes all the dormant and discontinued pipeline projects
* Latest company statement
* Latest news and deals relating to the ArmaGen Technologies Inc.'s pipeline products
Reasons to Get this Report
* Evaluate ArmaGen Technologies Inc.'s strategic position with total access to detailed information on its product pipeline
* Assess the growth potential of ArmaGen Technologies Inc. in its therapy areas of focus
* Identify new drug targets and therapeutic classes in the ArmaGen Technologies Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
* Develop strategic initiatives by understanding the focus areas of ArmaGen Technologies Inc. and exploit collaboration and partnership opportunities
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Plan mergers and acquisitions effectively by identifying the most promising pipeline of ArmaGen Technologies Inc.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Explore the dormant and discontinued projects of ArmaGen Technologies Inc. and identify potential opportunities in those areas
* Avoid Intellectual Property Rights related issues
Companies Mentioned in this Report: ArmaGen Technologies Inc.
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
ArmaGen Technologies Inc. Snapshot
ArmaGen Technologies Inc. Overview
Key Information
Key Facts
ArmaGen Technologies Inc. - Research and Development Overview
Key Therapeutic Areas
ArmaGen Technologies Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
ArmaGen Technologies Inc. - Pipeline Products Glance
ArmaGen Technologies Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ArmaGen Technologies Inc. - Drug Profiles
AGT-110
Product Description
Mechanism of Action
R&D Progress
AGT-115
Product Description
Mechanism of Action
R&D Progress
AGT-160
Product Description
Mechanism of Action
R&D Progress
AGT-181
Product Description
Mechanism of Action
R&D Progress
AGT-182
Product Description
Mechanism of Action
R&D Progress
AGT-183
Product Description
Mechanism of Action
R&D Progress
AGT-190
Product Description
Mechanism of Action
R&D Progress
AGT-184
Product Description
Mechanism of Action
R&D Progress
ArmaGen Technologies Inc. - Pipeline Analysis
ArmaGen Technologies Inc. - Pipeline Products by Target
ArmaGen Technologies Inc. - Pipeline Products by Route of Administration
ArmaGen Technologies Inc. - Pipeline Products by Molecule Type
ArmaGen Technologies Inc. - Pipeline Products by Mechanism of Action
ArmaGen Technologies Inc. - Recent Pipeline Updates
ArmaGen Technologies Inc. - Dormant Projects
ArmaGen Technologies Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
ArmaGen Technologies Inc. Key Information
ArmaGen Technologies Inc. Key Facts
ArmaGen Technologies Inc. - Pipeline by Indication 2014
ArmaGen Technologies Inc. - Pipeline by Stage of Development 2014
ArmaGen Technologies Inc. - Monotherapy Products in Pipeline 2014
ArmaGen Technologies Inc. - Preclinical 2014
ArmaGen Technologies Inc. - Discovery 2014
Full Table of Contents is available at:
-- http://www.fastmr.com/prod/900898_armagen_technologies_inc_product_pipeline_review.aspx?dt=t&afid=101
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts we provide quick and easy access to the best competitive intelligence available. Our unbiased expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.